Login / Signup

Seven-Day Vonoprazan-Based Triple Therapy as First-Line Helicobacter pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial.

Yu-Tse ChiuFu-Jen LeeChen-Ya KuoYu-Tsung ChenYang-Chao LinKai-Shun LiangChun-Ying WuRo-Ting LinJaw-Town LinChi-Yang Chang
Published in: Helicobacter (2024)
ClinicalTrials.gov identifier: NCT05371249.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • mesenchymal stem cells
  • replacement therapy
  • combination therapy